Relapse to Opioid Use in Opioid-Dependent Individuals Released from Compulsory Drug Detention Centres Compared with Those from Voluntary Methadone Treatment Centres in Malaysia : A Two-Arm, Prospective Observational Study

Detention of people who use drugs into compulsory drug detention centres (CDDCs) is common throughout East and Southeast Asia. Evidence-based pharmacological therapies for treating substance use disorders, such as opioid agonist treatments with methadone, are generally unavailable in these settings. We used a unique opportunity where CDDCs coexisted with voluntary drug treatment centres (VTCs) providing methadone in Malaysia to compare the timing and occurrence of opioid relapse (measured using urine drug testing) in individuals transitioning from CDDCs versus methadone maintenance in VTCs. Opioid-dependent individuals in CDDCs are significantly more likely to relapse to opioid use after release, and sooner, than those treated with evidence-based treatments such as methadone, suggesting that CDDCs have no role in the treatment of opioid-use disorders.

Saved in:
Bibliographic Details
Main Authors: Wegman, Martin P., Altice, Frederick L., Kaur, Sangeeth, Rajandaran, Vanessa, Osornprasop, Sutayut, Wilson, David, Wilson, David P., Kamarulzaman, Adeeba
Format: Journal Article biblioteca
Published: Elsevier 2017-02
Subjects:DRUG TREATMENT CENTERS, OPIOID ADDICTION, DRUG ADDICTION, VOLUNTARY COMMITMENT, COMPULSORY DETENTION, DRUG TESTING, PHARMACOLOGICAL THERAPY,
Online Access:http://hdl.handle.net/10986/29360
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Detention of people who use drugs into compulsory drug detention centres (CDDCs) is common throughout East and Southeast Asia. Evidence-based pharmacological therapies for treating substance use disorders, such as opioid agonist treatments with methadone, are generally unavailable in these settings. We used a unique opportunity where CDDCs coexisted with voluntary drug treatment centres (VTCs) providing methadone in Malaysia to compare the timing and occurrence of opioid relapse (measured using urine drug testing) in individuals transitioning from CDDCs versus methadone maintenance in VTCs. Opioid-dependent individuals in CDDCs are significantly more likely to relapse to opioid use after release, and sooner, than those treated with evidence-based treatments such as methadone, suggesting that CDDCs have no role in the treatment of opioid-use disorders.